HIV Drug Resistance

Authors:
  • ACAlexandra Calmy
    Alexandra Calmy
  • FPFernando Pascual
    Fernando Pascual
  • NFNathan Ford
    Nathan Ford

Abstract
Clavel and Hance (March 4 issue)1 review resistance to drugs used for the treatment of human immunodeficiency virus infection. Few data are available concerning patterns of antiretroviral-drug resistance among patients in developing countries. However, the fact that the expected virologic success rates of commonly used regimens containing nucleoside reverse-transcriptase inhibitors is approximately 65 percent at 48 weeks is cause for alarm.2